BK Digital is a multi-disciplinary Digital and Social Media consultancy born out of Marketing and Public Relations in the Pharma, Healthcare and Consumer product industries.Continue reading BK Digital: A Fresh Approach to Digital and Social Media Consulting for Agencies and Companies
With nearly a decade working in the rapidly evolving industry, I’ve noticed a variety of reasons why the pitch process, relationships between digital/social experts, account teams at agencies and properly following through on execution are not working smoothly. This is one of the core reasons behind Pharma’s lack of progress – not to minimize regulatory hurdles at all – but we also need to recognize that traditional PR, advertising, marketing processes and people are being deployed into what is a very complex, dynamic environment. Continue reading A Call for the Digital/Social Expert [Consultant] as a Priority Partner
Still waiting for the FDA to tell Pharma what we can do in Social Media? Folks, we already have our guidelines. Reading an old article last night (note: from Jan 2014) made me realize some of the real reasons behind Pharma’s struggle with social media – and it’s not because of the FDA or lack of guidance. While theContinue reading Pharma, We Already Have Our FDA Social Media Guidelines
In my eyes, we’ve only uncovered the tip of the iceberg for health and mobile, it has always just been a matter of avoiding the giant block of ambiguous ice that lives underneath that tip – but with the proper navigation, the opportunity for innovation and success is unlimited. The caution comes mostly in the fear of riskContinue reading Pharma Mobile Apps Are Not Dead and Kudos Sanofi, But More Can Be Done
This one’s tricky. As a digital strategist, I ask myself this question all the time and have almost too much of a hard time explaining it when asked. The truth is that digital strategy is fairly intangible. It’s a combination of experience rooted in many different fields and it means balancing those fields to meetContinue reading What Exactly is this “Digital Strategy” Thing?
Translation: What aspects of social media is pharma responsible for and the process for interacting in real-time while adhering to FDA postmarketing submission guidelines. On the path to releasing full guidance for pharma promotional activities in social media in July 2014, yesterday, the Food and Drug Administration (FDA) released draft guidance for comment, specific toContinue reading Explained: New FDA Guidance on Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media
One month ago, we organized an event known as Pioneers in Digital Health, a gathering of marketing and healthcare communications leaders for a forum meant to explore the latest and greatest in healthcare and digital. While there were some great key takeaways we heard from our attendees, I felt that there was a core message thatContinue reading Digital Pioneers – What Did We Learn?
From 2011-2012 Over the last year, we’ve seen digital and social mature more than any year before. What I mean by mature is not just the number of users on social platforms (that was set into endless motion in years past), but the increased specialization we’re seeing within each platform. For example, Twitter as aContinue reading Digital from 2011 to 2012 and What to Look Out For
First, let’s note that this document does not provide any new regulations regarding the industry’s use of digital and social media. Instead, these guidelines respond to requests that the FDA clarify the specific regulations for placement, size and prominence of brand names vs. generic names appearing in promotional advertisements (print, audio/video and online). Below isContinue reading New FDA Guidance Clarifies Brand & Generic Name Inclusion in Print, Broadcast and Online Media
